First Page | Document Content | |
---|---|---|
Date: 2010-04-29 14:53:44Antiprotozoal agents Antifungals Visceral leishmaniasis Tropical diseases HIV/AIDS Leishmaniasis Leishmania Amphotericin B Miltefosine Medicine Microbiology Health | Microsoft Word - Kala Azar Fact Sheet Page 2Add to Reading ListSource URL: www.msf.chDownload Document from Source WebsiteFile Size: 216,05 KBShare Document on Facebook |
ismp-hosp-temp-MASTER.qxdDocID: 1qIK8 - View Document | |
article published online: 1 june 2015 | doi: nchembio.1821 Nontoxic antimicrobials that evade drug resistance Stephen A Davis1,2, Benjamin M Vincent3,4, Matthew M Endo1,2, Luke Whitesell4, Karen Marchillo5,6, DavDocID: 1pvkH - View Document | |
PRESS RELEASE F2G Ltd announces the appointment of Ralf Schmid to the position of Chief Financial Officer MANCHESTER, UK – 11 JulyF2G Ltd, the UK-based antifungal drug discovery and development company, today aDocID: 1oWNB - View Document | |
Report 2014 Aspergillus working groupDocID: 1o3re - View Document | |
Amphotericin B Analogs Boast Lower Toxicity | June 8, 2015 Issue Vol. 93 Issue 23 | Chemical & Engineering NewsDocID: 1gOcD - View Document |